Janux Therapeutics, Inc. (JANX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 61.50 |
| Open | 53.68 |
| Bid | 55.05 x 200 |
| Ask | 55.80 x 400 |
| Day's Range | 51.66 - 58.00 |
| 52 Week Range | 5.65 - 65.60 |
| Volume | |
| Avg. Volume | 1,069,591 |
| Market Cap | 2.871B |
| Beta (5Y Monthly) | 4.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.32 |
| Earnings Date | May 10, 2024 - May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.29 |
GuruFocus.comJanux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
Detailed Analysis of Janux Therapeutics' First Quarter 2024 Financials and Business Updates
Business WireJanux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
SAN DIEGO, May 07, 2024--Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
ZacksHere's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
Janux Therapeutics (JANX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.